In silico and in vitro analysis of the genotoxic and mutagenic potential of STING modulators
Santosh Vishwakarma, Saketh Sriram Dinavahi, Kapil R Nikam, Bibhuti Ranjan et autres
in (code pays fourni par la source)
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
Santosh Vishwakarma, Saketh Sriram Dinavahi, Kapil R Nikam, Bibhuti Ranjan et autres
in (code pays fourni par la source)
Yu‐Chi Chen, Christopher G. Bazewicz, Saketh Sriram Dinavahi, Nicholas D. Huntington et autres
The p53 pathway plays an important role in role in cancer immunity. Mutation or downregulation of the proteins in the p53 pathway are prevalent in many cancers, contributing to tumor progression and immune dysregulation. Recent findings suggest that the activity of p53 …
us (code pays fourni par la source)
Venugopal Vangala, Yu‐Chi Chen, Saketh Sriram Dinavahi, Krishne Gowda et autres
The goal of this project was to demonstrate that subpopulations of cells in tumors can uniquely fluctuate in size in response to environmental conditions created during drug treatment, thereby acting as a dynamic “rheostat” to create a favorable tumor environment for growth. …
us (code pays fourni par la source)
Saketh Sriram Dinavahi, Yu‐Chi Chen, Kishore Punnath, Arthur S Berg et autres
Abstract Immunotherapy has revolutionized cancer treatment. Unfortunately, most tumor types do not respond to immunotherapy due to a lack of immune infiltration or “cold” tumor microenvironment (TME), a contributing factor in treatment failure. Activation of the p53 pathway can increase apoptosis of …
Saketh Sriram Dinavahi, Yu‐Chi Chen, Kishore Punnath, Arthur S Berg et autres
Supplementary Figure from Targeting WEE1/AKT Restores p53-Dependent Natural Killer–Cell Activation to Induce Immune Checkpoint Blockade Responses in “Cold” Melanoma
Saketh Sriram Dinavahi, Yu‐Chi Chen, Kishore Punnath, Arthur S Berg et autres
Abstract Immunotherapy has revolutionized cancer treatment. Unfortunately, most tumor types do not respond to immunotherapy due to a lack of immune infiltration or “cold” tumor microenvironment (TME), a contributing factor in treatment failure. Activation of the p53 pathway can increase apoptosis of …
Saketh Sriram Dinavahi, Yu‐Chi Chen, Kishore Punnath, Arthur S Berg et autres
Supplementary Figure from Targeting WEE1/AKT Restores p53-Dependent Natural Killer–Cell Activation to Induce Immune Checkpoint Blockade Responses in “Cold” Melanoma
Saketh Sriram Dinavahi, Yu‐Chi Chen, Kishore Punnath, Arthur S Berg et autres
Immunotherapy has revolutionized cancer treatment. Unfortunately, most tumor types do not respond to immunotherapy due to a lack of immune infiltration or "cold" tumor microenvironment (TME), a contributing factor in treatment failure. Activation of the p53 pathway can increase apoptosis of cancer …
us (code pays fourni par la source)
Saketh Sriram Dinavahi, Yu‐Chi Chen, Raghavendra Gowda, Pavan Kumar Dhanyamraju et autres
Decreasing the levels of certain proteins has been shown to be important for controlling cancer but it is currently unknown whether proteins could potentially be targeted by the inhibiting of protein synthesis. Under this circumstance, targeting protein translation could preferentially affect certain …
us (code pays fourni par la source)
Yu‐Chi Chen, Saketh Sriram Dinavahi, Qilong Feng, Raghavendra Gowda et autres
us (code pays fourni par la source)
Gregory R. Kardos, Raghavendra Gowda, Saketh Sriram Dinavahi, Scot R. Kimball et autres
Increased protein synthesis is a key process in melanoma, which is regulated by the ALDH18A1 gene encoding pyrroline-5-carboxylate synthase (P5CS). P5CS is involved in proline biosynthesis and targeting ALDH18A1 has previously been shown to inhibit melanoma development by decreasing intracellular proline levels …
us (code pays fourni par la source)
Raghavendra Gowda, Bailey M. Robertson, Soumya Iyer, John Mitchell Barry et autres
us (code pays fourni par la source)
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.
L'essentiel de l'actu tech du Burkina & d'Afrique, chaque semaine dans votre boîte mail.
Gratuit · sans spam · désinscription en un clic